Evidence map›Paper›PMID 35008718›Full record

ArticleInternational journal of molecular sciences2021

Enhanced BMP-2-Mediated Bone Repair Using an Anisotropic Silk Fibroin Scaffold Coated with Bone-like Apatite.

Christian Deininger, Andrea Wagner, Patrick Heimel, Elias Salzer, Xavier Monforte Vila, Nadja Weißenbacher, Johannes Grillari, Heinz Redl, Florian Wichlas, Thomas Freude and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Anatomical implant region - a critical determinant for the osteogenic potency of small extracellular vesicles and rhBMP-2.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Christian DeiningerInstitute of Tendon and Bone Regeneration, Spinal Cord Injury & Tissue Regeneration Center Salzburg, 5020 Salzburg, Austria.
Andrea WagnerInstitute of Tendon and Bone Regeneration, Spinal Cord Injury & Tissue Regeneration Center Salzburg, 5020 Salzburg, Austria.
Patrick HeimelAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
Elias SalzerAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
Xavier Monforte VilaAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
Nadja WeißenbacherInstitute of Tendon and Bone Regeneration, Spinal Cord Injury & Tissue Regeneration Center Salzburg, 5020 Salzburg, Austria.
Johannes GrillariAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.ORCID 0000-0001-5474-6332
Heinz RedlAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.ORCID 0000-0003-1654-462X
Florian WichlasDepartment of Orthopedics and Traumatology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.
Thomas FreudeDepartment of Orthopedics and Traumatology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.
Herbert TempferInstitute of Tendon and Bone Regeneration, Spinal Cord Injury & Tissue Regeneration Center Salzburg, 5020 Salzburg, Austria.
Andreas Herbert Teuschl-WollerAustrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.ORCID 0000-0002-3817-1572
Andreas TrawegerInstitute of Tendon and Bone Regeneration, Spinal Cord Injury & Tissue Regeneration Center Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-0220-4766
Austrian Cluster for Tissue Regeneration · ATParacelsus Medical University · ATUniversity of Applied Sciences Technikum Wien · ATLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA · ATInstitute of Molecular Biotechnology · AT

Funding

Lorenz Böhler Gesellschaft 04/16
6 · The paper itself

Abstract

The repair of large bone defects remains challenging and often requires graft material due to limited availability of autologous bone. In clinical settings, collagen sponges loaded with excessive amounts of bone morphogenetic protein 2 (rhBMP-2) are occasionally used for the treatment of bone non-unions, increasing the risk of adverse events. Therefore, strategies to reduce rhBMP-2 dosage are desirable. Silk scaffolds show great promise due to their favorable biocompatibility and their utility for various biofabrication methods. For this study, we generated silk scaffolds with axially aligned pores, which were subsequently treated with 10× simulated body fluid (SBF) to generate an apatitic calcium phosphate coating. Using a rat femoral critical sized defect model (CSD) we evaluated if the resulting scaffold allows the reduction of BMP-2 dosage to promote efficient bone repair by providing appropriate guidance cues. Highly porous, anisotropic silk scaffolds were produced, demonstrating good cytocompatibility in vitro and treatment with 10× SBF resulted in efficient surface coating. In vivo, the coated silk scaffolds loaded with a low dose of rhBMP-2 demonstrated significantly improved bone regeneration when compared to the unmineralized scaffold. Overall, our findings show that this simple and cost-efficient technique yields scaffolds that enhance rhBMP-2 mediated bone healing.

Indexed as

Adenosine TriphosphateAnimalsAnisotropyApatitesBiomimetic MaterialsBone and BonesBone Morphogenetic Protein 2Bone RegenerationCaspase 7CaspasesFemurFibroinsFreezingHumansMaleRatsAdenosine TriphosphateApatitesBone Morphogenetic Protein 2Caspase 7CaspasesFibroinsrecombinant human bone morphogenetic protein-2Recombinant ProteinsTransforming Growth Factor betabone regenerationcritical sized defectnonunionpseudarthrosissilk scaffold

Identifiers

PMID35008718
PMCPMC8745248
OpenAlexW4200319756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.